Breast Imaging Market Worth $9.0 Billion by 2030 at CAGR 8.6%: Grand View Research, Inc.
SAN FRANCISCO, Dec. 12, 2022 /PRNewswire/ -- The global breast imaging market size is anticipated to reach USD 9.0 billion by 2030, registering a CAGR of 8.6% according to a new report by Grand View Research, Inc. The market growth mainly owes to the increase in the number of women suffering from breast cancer.
Key Industry Insights & Findings from the report:
The ionizing segment dominated the technology segment in 2022 owing to the introduction of new ionizing technology-based breast imaging technologies.
Hospitals dominated the end-use segment in 2022 due to the presence of advanced and well-equipped breast imaging facilities.
In 2022, North America dominated the breast imaging market with a market share of 37.87% 2022. This can be accredited to the rising number of breast cancer cases in this region.
Asia Pacific is projected to impel at the fastest growth rate of CAGR 9.5% during the forecast duration. Increased prevalence of breast cancer, high R&D investments in breast cancer therapies, and developments in breast imaging modalities are the primary drivers driving the growth of the market.
According to Robert Koch Institute, the annual incidence of breast cancer in Germany was estimated to be approximately 72,000, with breast cancer being the most prevalent cancer in women. Moreover, as per a similar source, based on the incidence rate, one in eight women is expected to suffer from breast cancer once in a lifetime. Thus, impelling the market over the forecast period.
Furthermore, the rising initiatives by various governments and NGOs to raise awareness about early diagnosis of breast cancer are anticipated to increase the demand for breast imaging. For instance, Pink Initiative, form Breast Cancer India is an online initiative program in which the program covers important topics such as early detection of breast cancer, and familial breast cancer, through their YouTube channel. Similarly, a joint initiative between Australian & state territory governments, 'BreastScreen Australia' is aimed at reducing deaths & illness from breast cancer by early detecting cancer. In this program, women aged 40 and above can have a free mammogram every 2 years. This is expected to increase awareness, and increase the demand for breast imaging, thereby, propelling the market growth.
Major manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years. For instance, in March 2018, The MAMMOMAT Revelation platform, from Siemens Healthineers, for enhanced mammography has been approved by the U.S. FDA. To target afflicted areas with only one click, this platform combines a new InSpect specimen imaging tool and new HD Breast Biopsy technology. In addition, the use of artificial intelligence (AI) in breast imaging has reduced the time required while maintaining image quality. Such product developments are expected to propel market growth.
Breast Imaging Market Segmentation
Grand View Research has segmented the global breast imaging market based on technology, end-use, and region:
Breast Imaging Market - Technology Outlook (Revenue, USD Million; 2018 - 2030)
Breast Imaging Market - End-use Outlook (Revenue, USD Million; 2018 - 2030)
Hospitals
Breast Care Centers
Diagnostic Imaging Centers
Breast Imaging Market - Regional Outlook (Revenue, USD Million; 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
India
China
Australia
Thailand
South Korea
Latin America
Mexico
Brazil
Argentina
MEA
South Africa
Saudi Arabia
Kuwait
UAE
List of Key Players in the Breast Imaging Market
GE Healthcare,
Hologic, Inc.,
Philips Healthcare
Gamma Medica, Inc.
Siemens Healthcare
Fujifilm Holdings Corp.
SonoCine, Inc.,
Toshiba Corporation,
Dilon Technologies, Inc.,
Aurora Imaging Technology, Inc.
Check out more related studies published by Grand View Research:
Breast Implants Market - The global breast implants market size is anticipated to reach USD 4.11 billion by 2030, expanding at a CAGR of 7.4%, according to a new report by Grand View Research, Inc. increasing focus on the enhancement of physical appearance has led to the growth of the market.
Automated Breast Ultrasound Market - The global automated breast ultrasound market size is expected to reach USD 3.6 billion by 2026, expanding at a CAGR of 15.0%, according to a new report by Grand View Research, Inc. The rising incidence of this form of cancer, technological advancement, and various initiatives undertaken to raise awareness regarding cancer across the globe are expected to propel market growth.
Breastfeeding Accessories Market - The global breastfeeding accessories market size is expected to reach USD 3.90 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.45% from 2022 to 2030. An increasing women's employment rate is expected to surge the demand for breastfeeding accessories, thereby propelling the market growth.
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.
The focus of the collaboration is to...
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....